Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:BFLY NASDAQ:LMAT NASDAQ:NPCE NASDAQ:PLSE On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBFLYButterfly Network$8.95+0.7%$5.36$1.32▼$9.69$2.26B2.2210.54 million shs12.94 million shsLMATLeMaitre Vascular$96.00+0.4%$99.86$79.00▼$118.01$2.19B0.54332,691 shs397,967 shsNPCENeuroPace$16.53+0.4%$16.35$7.56▼$19.60$561.52M1.88175,312 shs161,128 shsPLSEPulse Biosciences$29.24+2.8%$24.42$12.56▼$31.00$1.97B1.65361,725 shs466,619 shs(Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBFLYButterfly Network+1.66%+23.19%+99.11%+121.75%+360.15%LMATLeMaitre Vascular+0.36%+8.34%+1.43%-12.06%+16.26%NPCENeuroPace+0.36%+7.55%-0.06%+25.70%+54.34%PLSEPulse Biosciences+2.78%+13.73%+16.96%+35.43%+93.90%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBFLYButterfly Network$8.95+0.7%$5.36$1.32▼$9.69$2.26B2.2210.54 million shs12.94 million shsLMATLeMaitre Vascular$96.00+0.4%$99.86$79.00▼$118.01$2.19B0.54332,691 shs397,967 shsNPCENeuroPace$16.53+0.4%$16.35$7.56▼$19.60$561.52M1.88175,312 shs161,128 shsPLSEPulse Biosciences$29.24+2.8%$24.42$12.56▼$31.00$1.97B1.65361,725 shs466,619 shs(Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBFLYButterfly Network+1.66%+23.19%+99.11%+121.75%+360.15%LMATLeMaitre Vascular+0.36%+8.34%+1.43%-12.06%+16.26%NPCENeuroPace+0.36%+7.55%-0.06%+25.70%+54.34%PLSEPulse Biosciences+2.78%+13.73%+16.96%+35.43%+93.90%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBFLYButterfly Network 2.33Hold$5.56-37.85% DownsideLMATLeMaitre Vascular 2.75Moderate Buy$112.6017.29% UpsideNPCENeuroPace 2.88Moderate Buy$18.8313.93% UpsidePLSEPulse Biosciences 2.50Moderate Buy$30.674.88% UpsideCurrent Analyst Ratings BreakdownLatest NPCE, LMAT, BFLY, and PLSE Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/24/2026NPCENeuroPace Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)6/4/2026PLSEPulse Biosciences Canaccord Genuity GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy$32.006/3/2026LMATLeMaitre Vascular Barrington ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOutperform$120.005/20/2026LMATLeMaitre Vascular Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeBuy (B-) ➝ Buy (B)5/15/2026NPCENeuroPace HC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$19.00 ➝ $20.005/6/2026BFLYButterfly Network Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)5/6/2026LMATLeMaitre Vascular Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeBuy (B) ➝ Buy (B-)5/6/2026LMATLeMaitre Vascular Barrington ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOutperform$105.00 ➝ $120.005/6/2026LMATLeMaitre Vascular Citizens JmpSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetMarket Outperform$118.00 ➝ $127.005/6/2026LMATLeMaitre Vascular Wells Fargo & CompanySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetEqual Weight$94.00 ➝ $104.004/21/2026PLSEPulse Biosciences Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)(Data available from 6/29/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBFLYButterfly Network$97.61M23.35N/AN/A$0.77 per share11.62LMATLeMaitre Vascular$249.60M8.79$2.91 per share32.96$17.35 per share5.53NPCENeuroPace$99.99M5.64N/AN/A$0.57 per share29.00PLSEPulse Biosciences$350K5,782.00N/AN/A$1.19 per share24.57Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBFLYButterfly Network-$77.06M-$0.30N/AN/AN/A-73.63%-34.41%-23.91%7/31/2026 (Estimated)LMATLeMaitre Vascular$57.73M$2.7135.4229.362.6624.35%15.36%9.78%8/4/2026 (Estimated)NPCENeuroPace-$21.47M-$0.65N/AN/AN/A-21.67%-108.20%-18.50%8/11/2026 (Estimated)PLSEPulse Biosciences-$72.78M-$1.10N/AN/AN/AN/A-86.67%-73.61%8/11/2026 (Estimated)Latest NPCE, LMAT, BFLY, and PLSE EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/12/2026Q1 2026NPCENeuroPace-$0.19-$0.13+$0.06-$0.20$21.65 million$22.00 million5/5/2026Q1 2026LMATLeMaitre Vascular$0.66$0.68+$0.02$0.68$66.67 million$66.55 million5/4/2026Q1 2026PLSEPulse Biosciences-$0.32-$0.27+$0.05-$0.27$0.25 million$0.40 million4/30/2026Q1 2026BFLYButterfly Network-$0.04-$0.03+$0.01-$0.05$26.08 million$26.53 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthBFLYButterfly NetworkN/AN/AN/AN/AN/ALMATLeMaitre Vascular$1.001.04%+16.05%36.90%14 YearsNPCENeuroPaceN/AN/AN/AN/AN/APLSEPulse BiosciencesN/AN/AN/AN/AN/ALatest NPCE, LMAT, BFLY, and PLSE DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date4/28/2026LMATLeMaitre Vascularquarterly$0.251%5/21/20265/21/20266/4/2026(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBFLYButterfly NetworkN/A4.023.03LMATLeMaitre Vascular0.4214.3212.20NPCENeuroPace4.085.384.35PLSEPulse BiosciencesN/A7.267.24Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBFLYButterfly Network37.85%LMATLeMaitre Vascular84.64%NPCENeuroPace78.83%PLSEPulse Biosciences76.95%Insider OwnershipCompanyInsider OwnershipBFLYButterfly Network21.99%LMATLeMaitre Vascular7.40%NPCENeuroPace20.50%PLSEPulse Biosciences74.00%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBFLYButterfly Network460254.63 million198.64 millionOptionableLMATLeMaitre Vascular49022.85 million21.16 millionOptionableNPCENeuroPace17034.09 million27.11 millionOptionablePLSEPulse Biosciences14069.21 million18.00 millionOptionableNPCE, LMAT, BFLY, and PLSE HeadlinesRecent News About These CompaniesWhat Do Pulse Biosciences’ New Equity Awards Reveal About Executive Compensation Trends?June 15, 2026 | kalkinemedia.comKWhat Could New Equity Awards Signal for Pulse Biosciences’ Ongoing Growth Efforts?June 15, 2026 | kalkinemedia.comKPulse Biosciences Shareholders Approve Board and Auditor SlateJune 12, 2026 | tipranks.comPulse Biosciences, Inc. (PLSE) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 TranscriptJune 10, 2026 | seekingalpha.comPulse Biosciences Updates 2026 Cardiac Ablation StrategyJune 10, 2026 | theglobeandmail.comPulse Bio to redeem remaining common stock warrantsJune 10, 2026 | seekingalpha.comDid New Analyst Coverage and Insider Buying Just Shift Pulse Biosciences' (PLSE) Investment Narrative?June 9, 2026 | finance.yahoo.comPulse Biosciences to Present at the Goldman Sachs 47th Annual Global Healthcare Conference 2026May 27, 2026 | businesswire.comHere's Why Pulse Biosciences, Inc (PLSE) is a Great Momentum Stock to BuyMay 26, 2026 | zacks.comWhy Pulse Biosciences, Inc.’s (PLSE) Stock Is Down 6.55%May 16, 2026 | aaii.comAPulse Biosciences, Inc. (PLSE) Presents at Bank of America Global Healthcare Conference 2026 Prepared Remarks TranscriptMay 13, 2026 | seekingalpha.comPulse Biosciences, Inc. (PLSE) Presents at Bank of America Global Healthcare Conference 2026 - SlideshowMay 13, 2026 | seekingalpha.comPulse Biosciences (NASDAQ:PLSE) CEO Acquires $295,350.00 in StockMay 12, 2026 | insidertrades.comPulse Biosciences Authorizes Insider Purchases Under Equity ProgramMay 11, 2026 | theglobeandmail.comIs Pulse Biosciences (PLSE) Quietly Redefining Its Core Identity Around Atrial Fibrillation?May 11, 2026 | finance.yahoo.comPLSE Q1 2026 Earnings TranscriptMay 8, 2026 | finance.yahoo.comPulse Biosciences to Present at the BofA Securities 2026 Healthcare ConferenceMay 8, 2026 | finance.yahoo.comPulse Biosciences, Inc. (PLSE) Q1 2026 Earnings Call TranscriptMay 8, 2026 | seekingalpha.comPulse Biosciences (PLSE) Upgraded to Buy: What Does It Mean for the Stock?May 7, 2026 | zacks.comPulse Biosciences Reports Business Updates and First Quarter 2026 Financial ResultsMay 4, 2026 | finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeNPCE, LMAT, BFLY, and PLSE Company DescriptionsButterfly Network NYSE:BFLY$8.95 +0.06 (+0.67%) Closing price 06/29/2026 03:59 PM EasternExtended Trading$8.88 -0.06 (-0.73%) As of 06/29/2026 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Butterfly Network, Inc. develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally. It offers Butterfly iQ, a handheld and single-probe whole body ultrasound system; Butterfly iQ+ and iQ3 ultrasound devices that can perform whole-body imaging in a single handheld probe integrated with the clinical workflow, and accessible on a user's smartphone, tablet, and almost any hospital computer system; and Butterfly iQ+ Vet, a handheld ultrasound system designed for veterinarians. The company also provides Butterfly system, which includes probes, and related accessories and software subscriptions to healthcare systems, physicians, and healthcare providers through a direct sales force, distributors, and eCommerce channel. In addition, it offers cloud-based software solutions to healthcare systems, teleguidance, in-app educational tutorials, and formal education programs through its Butterfly Academy software, as well as professional services for large scale deployments; and ScanLab, an education-only app provides written walkthroughs and reference imagery to guide real-time educational scanning, enhancing the learning process. Butterfly Network, Inc. was founded in 2011 and is headquartered in Burlington, Massachusetts.LeMaitre Vascular NASDAQ:LMAT$96.00 +0.34 (+0.36%) Closing price 06/29/2026 04:00 PM EasternExtended Trading$95.97 -0.03 (-0.03%) As of 06/29/2026 07:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature. The company also provides artegraft biologic graft, a bovine carotid artery used for dialysis access; XenoSure biologic patches, used for closure of vessels after surgical intervention; VascuCel and CardioCel biologic patches, used in vessel repair, heart repair and reconstruction, and neonatal repairs; cardiovascular patches; carotid shunts that temporarily shunt the blood to the brain during the removal of plaque in a carotid endarterectomy surgery; biosynthetic vascular graft indicated for lower extremity bypass and dialysis access; and vascular grafts used to bypass or replace diseased arteries. In addition, it offers radiopaque tape, a medical-grade tape applied to the skin that enables surgeons and interventionalists to cross-refer between the inside and the outside of a patient's body and allows them to locate tributaries or lesions beneath the skin. Further, the company provides valvulotomes, which cut or disrupt valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and closure systems to attach vessels to one another with titanium clips instead of sutures. It markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts.NeuroPace NASDAQ:NPCE$16.53 +0.06 (+0.36%) Closing price 06/29/2026 04:00 PM EasternExtended Trading$16.68 +0.15 (+0.90%) As of 06/29/2026 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating medically refractory focal epilepsy. It also records continuous brain activity data and enables clinicians to monitor patients in person and remotely. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. The company sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.Pulse Biosciences NASDAQ:PLSE$29.24 +0.79 (+2.78%) Closing price 06/29/2026 04:00 PM EasternExtended Trading$28.68 -0.56 (-1.93%) As of 06/29/2026 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas The AI Boom Has a Second Act—And It's Playing Out in Optics Gold’s 2026 Rally Has Cracked—Is It Time to Buy the Pullback? 5 Tech Stocks to Buy on the July Pullback Is OpenAI’s IPO Delay a Warning for AI Investors? onsemi: What the Market Gets Wrong, You Can Get Right 5 Places Investors Can Hide If the AI Trade Keeps Cracking MarketBeat Week in Review – 06/22 - 06/26 Qualcomm’s Investor Day Just Changed the Growth Story Forever Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
